Personalis, INC Form 4 insider transactions

NASDAQ
Richard Chen, Chief Medical Officer and EVP of Personalis, Inc., sold 5,055 shares of common stock on June 17, 2024, to cover tax withholding obligations.
NASDAQ
Personalis CFO Aaron Tachibana sold 7,176 shares of common stock on June 17, 2024, to cover tax withholding obligations from the settlement of vested restricted stock units.
NASDAQ
Stephen Michael Moore, SVP and Chief Legal Officer of Personalis, Inc., sold 1,585 shares of common stock on June 17, 2024, to cover tax withholding obligations.
NASDAQ
Director Woodrow A. Myers Jr. of Personalis, Inc. was granted 50,000 stock options on May 17, 2024.
NASDAQ
Director Lonnie Shoff acquired 50,000 stock options in Personalis, Inc. on May 17, 2024.
NASDAQ
Director Karin Eastham acquired 50,000 stock options in Personalis, Inc. on May 17, 2024.
NASDAQ
Director A. Blaine Bowman acquired 50,000 stock options in Personalis, Inc. on May 17, 2024.
NASDAQ
Director Olivia Kyusuk Bloom received a stock option grant for 50,000 shares of Personalis, Inc. common stock on May 17, 2024.
NASDAQ
Richard Chen, Chief Medical Officer and EVP of Personalis, Inc., sold 940 shares of common stock on May 17, 2024, to cover tax withholding obligations from vested restricted stock units.
NASDAQ
Personalis CFO Aaron Tachibana sold 1,333 shares of common stock on May 17, 2024, to cover tax withholding obligations from the settlement of vested restricted stock units.
NASDAQ
Stephen Michael Moore, SVP and Chief Legal Officer of Personalis, Inc., sold 1,731 shares of common stock on May 17, 2024, to cover tax withholding obligations.
NASDAQ
Director Kenneth J Widder acquired 50,000 stock options in Personalis, Inc. on May 17, 2024, according to a recent SEC filing.
NASDAQ
Stephen Michael Moore, SVP and Chief Legal Officer of Personalis, Inc., sold 4,523 shares of common stock on April 30, 2024, to cover tax withholding obligations.
NASDAQ
Personalis CEO Christopher Hall acquired 400,000 stock options on March 15, 2024, according to a Form 4 filing with the SEC.
NASDAQ
Richard Chen, Chief Medical Officer and EVP of Personalis, Inc., reports the acquisition of 175,000 stock options on March 15, 2024.
NASDAQ
Aaron Tachibana, CFO and COO of Personalis, Inc., reports the acquisition of stock options.
NASDAQ
Stephen Michael Moore, General Counsel of Personalis, Inc., reports the acquisition of stock options.
NASDAQ
Director Woodrow A. Myers Jr. of Personalis, Inc. (PSNL) recently purchased 10,000 shares of common stock at an average price of $1.67.